Clinical Trial Update: Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors [NA]

View source ↗

Summary

A clinical trial update for HPARSS aims to enhance sensory deficit screening in survivors of childhood cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Washington University School of Medicine | Conditions: Childhood Cancer | NA | Status: RECRUITING